Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 61-70 of 233

Page
per page
  1. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  2. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  3. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  4. M344
    A4105 M344
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,potent and cell-permeable
  5. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  6. Poly(I:C)
    B5551 Poly(I:C)
    Target: Toll-like receptors (TLRs)
    Summary: Toll-like receptor 3 (TLR3) agonist
      insoluble in DMSO; insoluble in EtOH; ≥21.5 mg/mL
  7. Sotrastaurin (AEB071)
    A8525 Sotrastaurin (AEB071)
    Target: PKC
    Summary: PKC inhibitor
      ≥21.9 mg/mL
  8. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  9. INCB28060
    A8448 INCB28060
    Target: c-MET
    Summary: C-Met inhibitor,ATP-competitive and novel
      insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
  10. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR inhibitor
      ≥21.55 mg/mL

Items 61-70 of 233

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 220item
  2. Natural Products 1 item
  3. Kits 2item
  4. Peptides 3item
  5. Cell Biology 1 item
  6. Peptides & Proteins 1 item
  7. Lab Reagents 3item
Reversibility
  1. Reversible 21item
  2. Irreversible 8item
Target
  1. Caspases 6item
  2. Cyclin-Dependent Kinases 13item
  3. Proteasome 5item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 11item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 4item
  10. CXCR 1 item
  11. Raf 8item
  12. Aurora Kinases 6item
  13. Bcl-xl 1 item
  14. Glycoproteins 1 item
  15. MDM2 1 item
  16. EZH2 3item
  17. mTOR 1 item
  18. Bromodomains 1 item
  19. AP-1 3item
  20. MMP 2item
  21. Myosin II ATPases 1 item
  22. FLT3 5item
  23. GSK-3 4item
  24. LPA Receptors 1 item
  25. P-glycoprotein (P-gp) 3item
  26. PLK 3item
  27. Chk 4item
  28. Eph Receptors 1 item
  29. VEGFR 12item
  30. PDGFR 9item
  31. c-Kit 6item
  32. RET 1 item
  33. Bromodomain-containing proteins(BRDs) 1 item
  34. Phosphodiesterases (PDEs) 1 item
  35. Hydrolase 1 item
  36. Thymidylate Synthase 1 item
  37. p38 1 item
  38. Bcr-Abl 2item
  39. MEK 2item
  40. PORCN 1 item
  41. DOT1L 1 item
  42. FGFR 2item
  43. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  44. Smoothened 2item
  45. Eukaryotic elongation factors 1 item
  46. MET 5item
  47. Ras 1 item
  48. Src 4item
  49. Trk Receptors 4item
  50. STAT 3item
  51. Microtubules/Tubulins 4item
  52. EGFR 4item
  53. Hedgehog 1 item
  54. Reverse Transcriptases 1 item
  55. ROCK 5item
  56. FAK 1 item
  57. JAK 2item
  58. p300 1 item
  59. Syk 1 item
  60. DNA-PK 1 item
  61. HSP90 1 item
  62. AMPK 2item
  63. CFTR 3item
  64. TNKS 1 item
  65. ErbB 2item
  66. Toll-like receptors (TLRs) 2item
  67. DNA Methyltransferases 1 item
  68. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  69. ERK 1 item
  70. c-MET 7item
  71. BMI-1 1 item
  72. PKC 3item
  73. Calpains 1 item
  74. HCV Proteases 1 item
  75. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  76. Lyn 1 item
  77. SGLT 1 item
  78. USP 1 item
  79. LRRK2 1 item
  80. Sphingosine kinases (SphKs) 1 item
  81. GTPases 1 item
  82. HIV-1 gp120 1 item
  83. Fatty-acid-binding proteins (FABPs) 1 item
  84. Tie-2 2item
  85. Granzyme B 1 item
  86. Free Fatty Acid Receptors 1 item
  87. phosphatases 1 item
  88. Autophagy 2item
  89. ATM/ATR 3item
  90. CK1 1 item
  91. Farnesyl Diphosphate Synthases 1 item
  92. Melatonin Receptors 1 item
  93. Peroxynitrite 1 item
  94. Ron 1 item
  95. Synthases/Synthetases 1 item
  96. MAGL 1 item
  97. NPY Receptors 1 item
  98. c-Fyn 1 item
  99. Histamine H1 Receptors 2item
  100. TRP Channel 1 item
  101. Apoptosis Inducers 1 item
  102. NO Donors / Precursors 1 item
  103. IL Receptors 1 item
  104. 15-lipoxygenases 1 item
  105. Peptidoglycan synthesis 1 item
  106. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  107. Aldosterone receptor 1 item
  108. DPP-4 1 item
  109. DREADD Ligands 1 item
  110. p53-MDM2 interaction 1 item
  111. c-Fms tyrosine kinase 1 item
  112. Ub-conjugating enzyme (E2) complex 1 item
  113. HCV polymerase 2item
  114. PC-PLC 1 item
  115. DCLK2 1 item
  116. Lck 1 item
  117. Bcl-w 1 item
  118. FXR 1 item
  119. ATM 1 item
  120. Sirtuin 1 item
  121. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 201item
  2. Cell Experiments 134item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 8item
  3. Adrenocortical Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 5item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 41item
  9. Cancer 136item
  10. Cholangiocarcinoma 2item
  11. Chronic Lymphocytic Leukemia 2item
  12. Clear Cell Renal Cell Carcinoma 1 item
  13. Colon Cancer 19item
  14. Colon Carcinoma 3item
  15. Colorectal Cancer 20item
  16. Diabetes 2item
  17. Fungal Infection 1 item
  18. Glioblastoma 10item
  19. Glioma 3item
  20. HCV 2item
  21. Hepatitis C 1 item
  22. Hepatocellular Carcinoma 4item
  23. HIV 2item
  24. Immunosuppressive Therapy 1 item
  25. Inflammatory Diseases 4item
  26. Leukemia 7item
  27. Liver Cancer 3item
  28. Lung Cancer 11item
  29. Lung Carcinoma 2item
  30. Lymphoma 7item
  31. Mantle Cell Lymphoma 2item
  32. Medulloblastoma 1 item
  33. Melanoma 15item
  34. Mixed Lineage Leukemia 1 item
  35. Multiple Myeloma 9item
  36. Neuroblastoma 2item
  37. Non-small Cell Lung Cancer 7item
  38. Non-small Cell Lung Carcinoma 1 item
  39. Ovarian Cancer 13item
  40. Pain Relief 1 item
  41. Pancreatic Cancer 16item
  42. Pancreatic Carcinoma 2item
  43. Prostate Cancer 17item
  44. Psoriasis 1 item
  45. Pulmonary Fibrosis 1 item
  46. Renal Cell Carcinoma 6item
  47. Rheumatoid Arthritis 3item
  48. Sleep Disorders 1 item
  49. Thyroid Cancer 4item
  50. Type 2 Diabetes 3item